Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000233338 | SCV000286045 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000353618 | SCV000410493 | likely benign | Coffin-Siris syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565223 | SCV000663890 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001570008 | SCV001794198 | likely benign | not provided | 2021-02-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000565223 | SCV002532895 | benign | Hereditary cancer-predisposing syndrome | 2020-10-18 | criteria provided, single submitter | curation | |
Ce |
RCV001570008 | SCV004137786 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | SMARCA4: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001570008 | SCV001807481 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001570008 | SCV001965548 | likely benign | not provided | no assertion criteria provided | clinical testing |